ClinicalTrials.gov
ClinicalTrials.gov Menu

Hepatitis C Virus (HCV) Treatment Completion or Withdrawal

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00674492
Recruitment Status : Completed
First Posted : May 8, 2008
Results First Posted : March 9, 2015
Last Update Posted : May 15, 2015
Sponsor:
Information provided by (Responsible Party):
VA Office of Research and Development

Brief Summary:
Qualitative pilot study of patients' views of their experience with antiviral treatment for hepatitis C.

Condition or disease
Hepatitis C

Detailed Description:
Qualitative pilot study of patient' views of their experiences with antiviral treatment for hepatitis C. Two groups of patients will be sampled: nine who completed a 24 or 48 week course of treatment and nine who withdrew from treatment prior to planned end. Interview data will be analyzed using narrative and grounded theory methods to identify attributes of treatment experience that may discriminate between completion and withdrawal.

Study Type : Observational
Actual Enrollment : 21 participants
Time Perspective: Retrospective
Official Title: Patients' View of Hepatitis C Treatment Completion or Withdrawal
Study Start Date : May 2008
Actual Primary Completion Date : August 2008
Actual Study Completion Date : August 2008

Resource links provided by the National Library of Medicine


Group/Cohort
Hepatitis C patients
patients who initiated antiviral treatment for hepatitis C



Primary Outcome Measures :
  1. Attributes of Treatment Experience [ Time Frame: Zero to five years since ending treatment. ]
    Four basic reasons for persisting in antiviral treatment were identified: cure the disease, concern about diminishing time to act (avoid bad end), demonstation of personal strength, and redemption for past behavior.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
VHA patients who ever initiated antiviral treatment for hepatitis C.
Criteria

Inclusion Criteria:

Ever initiated anitiviral treatment for hepatitis C.

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00674492


Locations
United States, Massachusetts
Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA
Bedford, Massachusetts, United States, 01730
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Principal Investigator: Jack A Clark, PhD Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA

Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00674492     History of Changes
Other Study ID Numbers: SHP 08-193
First Posted: May 8, 2008    Key Record Dates
Results First Posted: March 9, 2015
Last Update Posted: May 15, 2015
Last Verified: April 2015

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections